Uvea
Showing 1 - 25 of 32
Uveitis, Posterior, Uveitis, Intermediate, Panuveitis Trial in United States (Acthar Gel)
Terminated
- Uveitis, Posterior
- +2 more
- Acthar Gel
-
Clearwater, Florida
- +7 more
Jul 12, 2021
Monitoring Drug-induced Uveitis
Unknown status
- Uveitis
- +3 more
- Drugs inducing uveitis
-
Paris, FranceAP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
Sep 2, 2019
Uveitis With Biologic Drugs in Resistant Cases
Not yet recruiting
- Uveitis
- Biologic drugs
- (no location specified)
Apr 21, 2022
Cataract Trial in Italy, Slovakia, Spain (Chloroprocaine 3%, Tetracaine 0.5%)
Completed
- Cataract
- Chloroprocaine 3%
- Tetracaine 0.5%
-
Bologna, Italy
- +26 more
Apr 19, 2021
Cataract Senile Trial in Suceava (Intraocular lens)
Recruiting
- Cataract Senile
- Intraocular lens
-
Suceava, RomaniaDUO STIL SRL , Clinica Oftalmologica Medoptic
Aug 2, 2021
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)
Active, not recruiting
- Macular Edema
- Retinal Vein Occlusion
- KSI-301
- +2 more
-
Phoenix, Arizona
- +140 more
Jul 20, 2022
Uveal Melanoma, Metastatic Trial in Tampa (4.7 microCi 225Ac-MTI-201, 9.5 microCi of 225Ac-MTI-201, 19 microCi of 225Ac-MTI-201)
Recruiting
- Uveal Melanoma
- Metastatic
- 4.7 microCi 225Ac-MTI-201
- +11 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Aug 9, 2022
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (suprachoroidal CLS-TA, suprachoroidal sham, IVT aflibercept)
Terminated
- Macular Edema
- Retinal Vein Occlusion
- suprachoroidal CLS-TA
- +2 more
-
Peoria, Arizona
- +109 more
Mar 18, 2021
Optical Coherence Tomography (OCT) in Uveitis
Recruiting
- Uveitis
-
Portland, OregonOregon Health & Science University
Jul 13, 2021
Melanoma Trial in Jette, Brussels (follow up DW MRI)
Recruiting
- Melanoma
- follow up DW MRI
-
Jette, Brabant, Belgium
- +1 more
Dec 16, 2020
Uveitis, Lymphoma, NK-Cell Lymphoma Trial in Lyon (Blood sample)
Recruiting
- Uveitis
- +2 more
- Blood sample
-
Lyon, France
- +1 more
Dec 23, 2022
Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients
Recruiting
- Melanoma (Skin)
- +2 more
-
Evora, PortugalHospital Evora
May 30, 2022
Non-infectious Intermediate Uveitis, Non-infectious Posterior Uveitis, Non-infectious Panuveitis Trial in United Kingdom, United
Completed
- Non-infectious Intermediate Uveitis
- +2 more
- LFG316
- Conventional Therapy
-
Golden, Colorado
- +7 more
Dec 9, 2020
Patients With Newly Diagnosed Active NISU Trial in Avignon, Dijon (drug, other, biological)
Recruiting
- Patients With Newly Diagnosed Active NISU
- prednisone and ustekinumab treatment
- +3 more
-
Avignon, France
- +1 more
Apr 12, 2021
Treatment Outcome of Uveitis in Autoimmune Diseases
Unknown status
- Autoimmune Uveitis
- Corticosteroid Series
- (no location specified)
Mar 20, 2019
Cataract Trial in Ahaus (CT ASPHINA 509)
Terminated
- Cataract
- CT ASPHINA 509
-
Ahaus, GermanyAugenklinink
Jul 17, 2018
Cataract Trial in Linköping (CT ASPHINA 409)
Completed
- Cataract
- CT ASPHINA 409
-
Linköping, SwedenDepartment of Ophthalmology
Jul 17, 2018
Melanoma Trial in Dallas (Digoxin Combination, Dabrafenib, Trametinib)
Withdrawn
- Melanoma
- Digoxin Combination
- +2 more
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
May 9, 2018
Uveitis, Cytoid Macular Edema Trial in San Francisco (Ranibizumab)
Completed
- Uveitis
- Cytoid Macular Edema
-
San Francisco, CaliforniaProctor Foundation, UCSF
Oct 24, 2017
Uveitis Trial in Lyon (Free strategy, Standardized strategy)
Completed
- Uveitis
- Free strategy
- Standardized strategy
-
Lyon, FranceService de Médecine Interne, Hospices Civils de Lyon (HCL)-Hôpit
May 23, 2019
Juvenile Idiopathic Arthritis Trial in Worldwide (CP-690,550 (tofacitinib), )
Completed
- Juvenile Idiopathic Arthritis
- CP-690,550 (tofacitinib)
- placebo
-
Little Rock, Arkansas
- +102 more
Mar 30, 2020
Uveitis Trial run by the CC (Microplasmin)
Terminated
- Uveitis
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 3, 2018